Sionna Therapeutics, Inc.

Direct answer

Sionna Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SION.

Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular...

Can you invest in Sionna Therapeutics, Inc.?

Yes. Sionna Therapeutics, Inc. is publicly traded on NASDAQ under the ticker SION.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Sionna Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.